SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: A.J. Mullen who wrote (3344)8/1/2021 9:09:54 PM
From: CuttingEdge Bio  Read Replies (2) | Respond to of 3557
 
This is only for post-exposure prophylaxis, or "who are at high risk of exposure to an infected individual in an institutional setting"
It specifically excludes pre-exposure prophylaxis which they were hoping for to fully address the needs of immunocompromised patients. This severely restricts their ability to do that and makes it hard for such patients to access the drug.